Peramivir Trihydrate NEW
Price | $39 | $64 | $105 |
Package | 2mg | 5mg | 10mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-19 |
Product Details
Product Name: Peramivir Trihydrate | CAS No.: 1041434-82-5 |
Purity: ≥95% | Supply Ability: 10g |
Release date: 2024/11/19 |
Product Introduction
Bioactivity
Name | Peramivir Trihydrate |
Description | Peramivir Trihydrate (RWJ-270201) is a neuraminidase inhibitor (IC50: 0.09 nM) which prevents normal processing of virus particles such that virus particles are not released from infected cells. Peramivir Trihydrate is a cyclopentane derivative with activity against influenza A and B viruses. |
In vitro | When used in conjunction with favipiravir (20-40 mg/kg/day), peramivir (0.025-0.1 mg/kg/day) increases cell survival rates by 10-50%. At a dosage of 0.5 mg/kg/day, peramivir exhibits a protective effect against H1N1 in mice, covering about 30% of the virus. The combination of peramivir (1 mg/kg/day) with amantadine (5-10 mg/kg/day) results in weight losses of 1.69 and 0.69, respectively; however, for a sub-lethal influenza A (H3N2) virus model in mice, administering peramivir (3 mg/kg/day) alongside rimantadine (10-30 mg/kg/day) does not affect weight. At a higher concentration, peramivir (30 mg/kg) effectively extends the survival of mice infected with the systemically replicating H5N1 virus. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | H2O : 6.6 mg/mL (17.26 mM), Sonication is recommended. |
Keywords | RWJ-270201 Trihydrate | inhibit | Peramivir Trihydrate | BCX 1812 Trihydrate | S021812 | RWJ 270201 Trihydrate | RWJ 270201 | BCX1812 | Inhibitor | RWJ270201 | Influenza Virus | Peramivir | RWJ270201 Trihydrate | S 021812 | BCX 1812 | BCX1812 Trihydrate | BCX-1812 Trihydrate |
Inhibitors Related | Curcumin | Crystal Violet |
Related Compound Libraries | Bioactive Compound Library | EMA Approved Drug Library | Drug Repurposing Compound Library | Anti-Viral Compound Library | Inhibitor Library | FDA-Approved Drug Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/1kg |
VIP1Y
|
Shandong Huizhihan Supply Chain Co., Ltd
|
2024-12-11 | |
$0.00/1kg |
VIP5Y
|
Jinan Jianfeng Chemical Co., Ltd
|
2024-08-08 | |
$0.00/1kg |
VIP2Y
|
Hangzhou ICH Biofarm Co., Ltd
|
2023-07-13 | |
$100.00/1KG |
Shijiazhuang Gantuo Biotechnology Co., Ltd
|
2023-03-10 | ||
$0.00/1kg |
VIP6Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2022-06-01 | |
$0.00/1G |
Senova Technology Co. Ltd.
|
2022-05-10 | ||
$200.00/1kg |
Hebei Mingeng Biotechnology Co., Ltd
|
2022-05-05 | ||
$0.00/1Kg/Bag |
VIP4Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2021-08-19 | |
$0.01/1KG |
VIP6Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-05-08 | |
$1.00/1kg |
VIP7Y
|
Career Henan Chemical Co
|
2018-12-17 |
- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY